Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

18 Dec 2018

M&A trends in the CRO industry

The global Contract Research Organization (CRO) market is continuing to see an increase in M&A transactions, a trend that has…

28 Aug 2018

A look at recent M&A activity in the CMO sector

When Catalent announced the completion of its acquisition of Juniper Pharma in mid-August, it was the latest deal in a…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

18 Mar 2019 - 8.00am-5.00pm

DCAT Week 2019

DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It…

23 Jun 2019 - 09.00am-6.00pm

DIA 2019 Global Annual Meeting

DIA’s Global Annual Meeting (DIA 2019) gathers stakeholders from across the world to openly knowledge share, generating insights beyond boundaries…

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office